SCHEMBL21532541

SCHEMBL21532541

c1ccc(-c2nnc(-c3cccc4c3c3ccccc3n4-c3ccccc3-c3ccccc3-n3c4ccccc4c4ccc5c6ccccc6oc5c43)n2-c2ccccc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
AKT1 P31749 2/20 0.33
AVPR1A P37288 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CA12 O43570 1/20 0.30
CA9 Q16790 1/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
ALOX5 P09917 1/20 0.30
HPGD P15428 1/20 0.30
LMNA P02545 1/20 0.30
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
BRCA1 P38398 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532685 0.97 KDM4E (0.34) KDM4EALDH1A1TSHRHSD17B10AKT1
SCHEMBL21532544 0.93 KDM4E (0.36) KDM4EALDH1A1TSHRHSD17B10AKT1
SCHEMBL21532469 0.93 ALDH1A1 (0.33) KDM4EALDH1A1TSHRHSD17B10AKT1
SCHEMBL21532483 0.93 ALDH1A1 (0.34) KDM4EALDH1A1TSHRHSD17B10AKT1
SCHEMBL21532605 0.91 ALDH1A1 (0.33) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532549 0.91 AKT1 (0.35) AKT1SMN1; SMN2ALOX5
SCHEMBL21532619 0.90 KDM4E (0.37) KDM4EALDH1A1TSHRHSD17B10AKT1
SCHEMBL21532296 0.90 ALDH1A1 (0.33) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532124 0.90 ALDH1A1 (0.34) KDM4EALDH1A1TSHRHSD17B10AKT1
SCHEMBL21532150 0.90 ALDH1A1 (0.35) KDM4EALDH1A1TSHRHSD17B10AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 KDM4E 4144/4885ALDH1A1 158/4885TSHR 3802/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 KDM4E 3893/4885ALDH1A1 283/4885TSHR 3504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.